Canlyniadau Chwilio - Perlman, Susan L

Modern Techniques of Pain Management gan Perlman, Susan L.

Cael y testun llawn Cael y testun llawn

Update on the Treatment of Ataxia: Medication and Emerging Therapies gan Perlman, Susan L.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinical Monitoring in a Patient with Friedreich Ataxia and Osteogenic Sarcoma gan Deutsch, Eric C., Seyer, Lauren A., Perlman, Susan L., Yu, Jeanette, Lynch, David R.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

C9ORF72 Expansion is Not a Significant Cause of Sporadic Spinocerebellar Ataxia gan Fogel, Brent L., Pribadi, Mochtar, Pi, Sarah, Perlman, Susan L., Geschwind, Daniel H., Coppola, Giovanni

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Mutations in PDYN are Not Responsible for Multiple System Atrophy gan Fogel, Brent L., Baker, Cameron, Curnow, Andrew, Perlman, Susan L., Geschwind, Daniel H., Coppola, Giovanni

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Childhood Ataxia: Clinical Features, Pathogenesis, Key Unanswered Questions, and Future Directions gan Ashley, Claire N., Hoang, Kelly D., Lynch, David R., Perlman, Susan L., Maria, Bernard L.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Frataxin deficiency impairs mitochondrial biogenesis in cells, mice and humans gan Jasoliya, Mittal J., McMackin, Marissa Z., Henderson, Chelsea K., Perlman, Susan L., Cortopassi, Gino A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A rapid, noninvasive immunoassay for frataxin: Utility in assessment of Friedreich ataxia gan Deutsch, Eric C., Santani, Avni B., Perlman, Susan L., Farmer, Jennifer M., Stolle, Catherine A., Marusich, Michael F., Lynch, David R.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Candidate Screening of the TRPC3 Gene in Cerebellar Ataxia gan Becker, Esther B. E., Fogel, Brent L., Rajakulendran, Sanjeev, Dulneva, Anna, Hanna, Michael G., Perlman, Susan L., Geschwind, Daniel H., Davies, Kay E.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinical data and characterization of the liver conditional mouse model exclude neoplasia as a non-neurological manifestation associated with Friedreich’s ataxia gan Martelli, Alain, Friedman, Lisa S., Reutenauer, Laurence, Messaddeq, Nadia, Perlman, Susan L., Lynch, David R., Fedosov, Kathrin, Schulz, Jörg B., Pandolfo, Massimo, Puccio, Hélène

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Dyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia gan Sahdeo, Sunil, Scott, Brian D., McMackin, Marissa Z., Jasoliya, Mittal, Brown, Brandon, Wulff, Heike, Perlman, Susan L., Pook, Mark A., Cortopassi, Gino A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Principal Component Analysis of Cerebellar Shape on MRI Separates SCA Types 2 and 6 into Two Archetypal Modes of Degeneration gan Jung, Brian C., Choi, Soo I., Du, Annie X., Cuzzocreo, Jennifer L., Geng, Zhuo Z., Ying, Howard S., Perlman, Susan L., Toga, Arthur W., Prince, Jerry L., Ying, Sarah H.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Relationships among Apathy, Health-Related Quality of Life and Function in Huntington’s disease gan Fritz, Nora E., Boileau, Nicholas R., Stout, Julie C., Ready, Rebecca, Perlmutter, Joel S., Paulsen, Jane S., Quaid, Kimberly, Barton, Stacey, McCormack, Michael K., Perlman, Susan L., Carlozzi, Noelle E.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Antioxidant use in Friedreich ataxia gan Myers, Lauren, Farmer, Jennifer M., Wilson, Robert B., Friedman, Lisa, Perlman, Susan L., Subramony, Sub H., Gomez, Christopher M., Ashizawa, Tetsuo, Wilmot, George R., Mathews, Katherine D., Balcer, Laura J., Lynch, David R.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

MRI shows a region-specific pattern of atrophy in spinocerebellar ataxia type 2 gan Jung, Brian C., Choi, Soo I., Du, Annie X., Cuzzocreo, Jennifer L., Ying, Howard S., Landman, Bennett A., Perlman, Susan L., Baloh, Robert W., Zee, David S., Toga, Arthur W., Prince, Jerry L., Ying, Sarah H.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Emerging therapies in Friedreich's ataxia gan Aranca, Tanya V, Jones, Tracy M, Shaw, Jessica D, Staffetti, Joseph S, Ashizawa, Tetsuo, Kuo, Sheng-Han, Fogel, Brent L, Wilmot, George R, Perlman, Susan L, Onyike, Chiadi U, Ying, Sarah H, Zesiewicz, Theresa A

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Body Mass Index and Height in the Friedreich Ataxia Clinical Outcome Measures Study gan Patel, Maya, McCormick, Ashley, Tamaroff, Jaclyn, Dunn, Julia, Mitchell, Jonathan A., Lin, Kimberly Y., Farmer, Jennifer, Rummey, Christian, Perlman, Susan L., Delatycki, Martin B., Wilmot, George R., Mathews, Katherine D., Yoon, Grace, Hoyle, Joseph, Corti, Manuela, Subramony, S.H., Zesiewicz, Theresa, Lynch, David, McCormack, Shana E.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Frataxin levels in peripheral tissue in Friedreich ataxia gan Lazaropoulos, Michael, Dong, Yina, Clark, Elisia, Greeley, Nathaniel R, Seyer, Lauren A, Brigatti, Karlla W, Christie, Carlton, Perlman, Susan L, Wilmot, George R, Gomez, Christoper M, Mathews, Katherine D, Yoon, Grace, Zesiewicz, Theresa, Hoyle, Chad, Subramony, Sub H, Brocht, Alicia F, Farmer, Jennifer M, Wilson, Robert B, Deutsch, Eric C, Lynch, David R

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study gan Ashizawa, Tetsuo, Figueroa, Karla P, Perlman, Susan L, Gomez, Christopher M, Wilmot, George R, Schmahmann, Jeremy D, Ying, Sarah H, Zesiewicz, Theresa A, Paulson, Henry L, Shakkottai, Vikram G, Bushara, Khalaf O, Kuo, Sheng-Han, Geschwind, Michael D, Xia, Guangbin, Mazzoni, Pietro, Krischer, Jeffrey P, Cuthbertson, David, Holbert, Amy Roberts, Ferguson, John H, Pulst, Stefan M, Subramony, SH

Cael y testun llawn Cael y testun llawn Cael y testun llawn

α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy gan Dutta, Suman, Hornung, Simon, Kruayatidee, Adira, Maina, Katherine N., del Rosario, Irish, Paul, Kimberly C., Wong, Darice Y., Duarte Folle, Aline, Markovic, Daniela, Palma, Jose-Alberto, Serrano, Geidy E., Adler, Charles H., Perlman, Susan L., Poon, Wayne W., Kang, Un Jung, Alcalay, Roy N., Sklerov, Miriam, Gylys, Karen H., Kaufmann, Horacio, Fogel, Brent L., Bronstein, Jeff M., Ritz, Beate, Bitan, Gal

Cael y testun llawn Cael y testun llawn Cael y testun llawn